NO962695L - Nye peptider som stammer fra autoantigen for anvendelse ved immunoterapi av autoimmunsykdommer - Google Patents

Nye peptider som stammer fra autoantigen for anvendelse ved immunoterapi av autoimmunsykdommer

Info

Publication number
NO962695L
NO962695L NO962695A NO962695A NO962695L NO 962695 L NO962695 L NO 962695L NO 962695 A NO962695 A NO 962695A NO 962695 A NO962695 A NO 962695A NO 962695 L NO962695 L NO 962695L
Authority
NO
Norway
Prior art keywords
autoantigen
peptides
seq
pct
autoimmune diseases
Prior art date
Application number
NO962695A
Other languages
English (en)
Other versions
NO962695D0 (no
NO316703B1 (no
Inventor
Anna Maria Helena Boots
Gijsbertus Francisc Verheijden
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO962695L publication Critical patent/NO962695L/no
Publication of NO962695D0 publication Critical patent/NO962695D0/no
Publication of NO316703B1 publication Critical patent/NO316703B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Rehabilitation Therapy (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19962695A 1994-10-27 1996-06-26 Nye peptider som stammer fra autoantigen, anvendelse derav, samt farmasoytisk og diagnostisk blanding, og diagnostisk fremgangsmate NO316703B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94203128 1994-10-27
EP95200886 1995-04-07
PCT/EP1995/004201 WO1996013517A1 (en) 1994-10-27 1995-10-25 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases

Publications (3)

Publication Number Publication Date
NO962695L true NO962695L (no) 1996-06-26
NO962695D0 NO962695D0 (no) 1996-06-26
NO316703B1 NO316703B1 (no) 2004-04-13

Family

ID=26136688

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19962695A NO316703B1 (no) 1994-10-27 1996-06-26 Nye peptider som stammer fra autoantigen, anvendelse derav, samt farmasoytisk og diagnostisk blanding, og diagnostisk fremgangsmate

Country Status (24)

Country Link
US (1) US5736507A (no)
EP (1) EP0733065B1 (no)
JP (1) JP3755894B2 (no)
KR (1) KR100485979B1 (no)
CN (1) CN1161379C (no)
AT (1) ATE177756T1 (no)
AU (1) AU696827B2 (no)
BR (1) BR9506377A (no)
CA (1) CA2173874A1 (no)
DE (1) DE69508380T2 (no)
DK (1) DK0733065T3 (no)
ES (1) ES2130672T3 (no)
FI (1) FI118472B (no)
GR (1) GR3030296T3 (no)
HK (1) HK1002012A1 (no)
HU (1) HU218027B (no)
IL (1) IL115744A (no)
MX (1) MX9602495A (no)
NO (1) NO316703B1 (no)
NZ (1) NZ295659A (no)
PL (1) PL183761B1 (no)
RU (1) RU2178797C2 (no)
TR (1) TR199501326A2 (no)
WO (1) WO1996013517A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843449A (en) * 1996-03-25 1998-12-01 Akzo Nobel N.V. Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
US6881824B1 (en) 1996-04-24 2005-04-19 Akzo Nobel N.V. Peptides suitable for use in antigen specific immunosuppressive therapy
TW575583B (en) * 1996-04-24 2004-02-11 Akzo Nobel Nv Novel peptides suitable for use in antigen specific immunosuppressive therapy
EP0947524A1 (en) * 1998-03-30 1999-10-06 Upither B.V. Novel peptides for the treatment of autoimmune diseases
AU5287599A (en) * 1998-07-23 2000-02-14 Akzo Nobel N.V. Use of hc gp-39 in immune diseases
EP1100823A2 (en) 1998-07-23 2001-05-23 Akzo Nobel N.V. Novel peptides for use in immunotherapy of autoimmune diseases
KR20020047245A (ko) * 1999-10-18 2002-06-21 에프.지.엠. 헤르만스 ; 이.에이치. 리링크 면역요법에 사용하기 위한 수정 펩티드 및 펩티드모방체
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
IL160000A0 (en) 2001-07-24 2004-06-20 Univ Yale Methods, compositions and kits relating to chitinases and chitinase-like molecules and imflammatory disease
US20050214297A1 (en) * 2004-02-25 2005-09-29 Medimmune, Inc. Methods and compositions relating to chitinases and chitinase-like molecules and modulation of osteoclasts
US20070071746A1 (en) * 2005-08-31 2007-03-29 Medimmune, Inc. C/CLP antagonists and methods of use thereof
RU2302872C9 (ru) * 2006-06-22 2008-12-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Средство, нормализующее функции хрящевой ткани, и способ его получения
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
AU2008288283B2 (en) 2007-08-15 2013-01-31 Circassia Limited Peptides for desensibilization against allergens
EP2331124A1 (en) * 2008-08-15 2011-06-15 Circassia Limited T-cell antigen peptide from allergen for stimulation of il-10 production
DK2153841T4 (en) 2008-08-15 2016-02-15 Circassia Ltd Vaccine comprising Amb a 1 peptides for use in the treatment of ambrosieallergi
PL2393830T3 (pl) 2009-02-05 2015-07-31 Circassia Ltd Peptydy traw dla szczepionki
PT2493487T (pt) * 2009-10-27 2016-11-08 Erytech Pharma Composição para induzir uma tolerância imunitária específica
EP3344575B1 (en) 2015-09-04 2020-04-15 SQZ Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6323898A (ja) * 1986-07-16 1988-02-01 Dainippon Pharmaceut Co Ltd 新規ポリペプチド及びそれをコ−ドするｄｎａ並びにそれらの製法
IL92629A0 (en) * 1989-12-10 1990-08-31 Yeda Res & Dev Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases
CA2164498C (en) * 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices

Also Published As

Publication number Publication date
BR9506377A (pt) 1997-09-16
AU3925295A (en) 1996-05-23
MX9602495A (es) 1997-05-31
TR199501326A2 (tr) 1996-06-21
US5736507A (en) 1998-04-07
PL183761B1 (pl) 2002-07-31
HU218027B (hu) 2000-05-28
ATE177756T1 (de) 1999-04-15
DK0733065T3 (da) 1999-10-11
RU2178797C2 (ru) 2002-01-27
FI118472B (fi) 2007-11-30
AU696827B2 (en) 1998-09-17
PL315198A1 (en) 1996-10-14
KR960705848A (ko) 1996-11-08
EP0733065B1 (en) 1999-03-17
NO962695D0 (no) 1996-06-26
DE69508380D1 (de) 1999-04-22
HK1002012A1 (en) 1998-07-24
CN1161379C (zh) 2004-08-11
FI962619A0 (fi) 1996-06-25
NZ295659A (en) 1998-02-26
JPH09507861A (ja) 1997-08-12
JP3755894B2 (ja) 2006-03-15
IL115744A (en) 2000-07-16
KR100485979B1 (ko) 2006-01-27
HUT74847A (en) 1997-02-28
IL115744A0 (en) 1996-01-19
WO1996013517A1 (en) 1996-05-09
CA2173874A1 (en) 1996-05-09
FI962619A (fi) 1996-06-25
ES2130672T3 (es) 1999-07-01
CN1168677A (zh) 1997-12-24
EP0733065A1 (en) 1996-09-25
DE69508380T2 (de) 1999-09-09
GR3030296T3 (en) 1999-09-30
NO316703B1 (no) 2004-04-13
HU9601401D0 (en) 1996-07-29

Similar Documents

Publication Publication Date Title
NO962695D0 (no) Nye peptider som stammer fra autoantigen for anvendelse ved immunoterapi av autoimmunsykdommer
Ugrinovic et al. A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis.
Taneja et al. HLA class II transgenic mice as models of human diseases
FI960980A0 (fi) Menetelmiä antigeenispesifisen T-solutoleranssin indusoimiseksi
ATE252640T1 (de) Verbindungen zur immunotherapie und diagnose von tuberkulose
NZ332311A (en) Use of autoantigen HC gp-39 and proteins structurally related thereto in immunotherapy of autoimmune diseases particularly rheumatoid arthritis
JP3445917B2 (ja) 抗原特異的活性化ｔ細胞
CY1109837T1 (el) Διαγνωστικο και θεραπευτικο επιτοπιο
ATE442439T1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
NZ332427A (en) Peptides suitable for use in antigen specific immunosuppressive therapy
Monneaux et al. Key sequences involved in the spreading of the systemic autoimmune response to spliceosomal proteins
ATE248602T1 (de) Verfahren zur isolierung von cda-präsentierten antigenen, cd1-präsentierte antigeneenthaltende impfstoffe und in besagten verfahren verwendbare zelllinien
ATE185151T1 (de) Neue peptide zur verwendung bei behandlung von durch t-zellen vermittelter knorpelzerstörungin autoimmunkrankheiten
Dayan et al. T cells involved in human autoimmune disease are resistant to tolerance induction.
Choudhury et al. Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool
TR200100175T2 (tr) Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler.
Benacerraf Biological function of HLA molecules
Buus et al. The Interaction between MHC Class II Molecules and Immunogenic Peptides
Qian et al. of March 2, 2014.